Sponsor:
ECOG-ACRIN Cancer Research Group
Code:
NCT03937635
Conditions
Smoldering Plasma Cell Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Daratumumab
Dexamethasone
Lenalidomide
Quality-of-Life Assessment
Questionnaire Administration
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations